Target intelligence / Profile preview

OVOL1 antisense RNA 1 (OVOL1-AS1)

Target
OVOL1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA
01

Overview

OVOL1 antisense RNA 1 (OVOL1-AS1) is a long non-coding RNA (lncRNA) transcribed from the opposite DNA strand of the OVOL1 gene. As an antisense RNA, it is presumed to regulate the expression of the neighboring OVOL1 gene through mechanisms such as transcriptional interference, alteration of chromatin state, or interaction with regulatory DNA elements. Antisense RNAs like OVOL1-AS1 typically function by binding to or modulating the activity of the sense (protein-coding) transcript, affecting gene expression post-transcriptionally or by influencing chromatin structure. Specific regulatory roles or disease associations for OVOL1-AS1 have not been characterized in the cited literature, but antisense RNAs in general are important modulators of gene expression, imprinting, and epigenetic processes. No small molecules, approved drugs, or developed therapeutics specifically target OVOL1-AS1 according to current data. OVOL1-AS1 is distinct from the protein-coding OVOL1 gene, which encodes a transcriptional repressor implicated in epithelial identity, cancer, and skin disease. OVOL1-AS1 itself is a regulatory RNA, not a protein, receptor, or enzyme. While antisense lncRNAs can play significant roles in disease via regulation of their sense gene, no direct evidence was found supporting OVOL1-AS1 as a therapeutic target or biomarker at this time.

Other names
OVOL1-AS1
02

Mechanism of action

Not established for drugs (lncRNAs may regulate their sense gene via transcriptional interference or modulation of chromatin, but no direct drug mechanisms identified)

03

Biological functions

Regulation of gene expressionTranscriptional interferenceEpigenetic regulation
04

Disease associations

Other (General modulatory roles in gene regulation; no specific disease association found in the retrieved sources)

Beyond the preview

Go deeper on OVOL1 antisense RNA 1 (OVOL1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OVOL1 antisense RNA 1 (OVOL1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call